RC
MLAB icon

Roubaix Capital’s Mesa Laboratories MLAB Stock Holding History

Roubaix Capital’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-72,115
Closed -$6.38M – 59
2026
Q1 		$6.38M Buy
72,115
+16,926
+31% +$1.46M 2.98% 10
2025
Q4 		$4.33M Sell
55,189
-21,468
-28% -$1.63M 1.85% 32
2025
Q3 		$5.14M Buy
+76,657
New +$5.52M 2.39% 18

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Roubaix Capital's MLAB Position: Q2 2026 in Review

Roubaix Capital sold out of Mesa Laboratories (MLAB) in Q2 2026, closing a stake of 72,115 shares — an estimated $6.38M sold.

Roubaix Capital first reported a position in MLAB in Q3 2025 and held it in 3 quarters. The position peaked at $6.38M in Q1 2026. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Roubaix Capital reported no remaining Mesa Laboratories position as of Q2 2026 after selling out during the quarter.
  • Roubaix Capital sold 72,115 Mesa Laboratories shares in Q2 2026, an estimated $6.38M.
  • Roubaix Capital first reported a position in Mesa Laboratories in Q3 2025 and held it in 3 quarters.
  • Roubaix Capital's Mesa Laboratories position peaked at $6.38M in Q1 2026.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Roubaix Capital's 13F filing for Q2 2026, filed 10 Aug 2026.